ES2188763T3 - Factor del tipo relaxina y metodos y usos del mismo. - Google Patents
Factor del tipo relaxina y metodos y usos del mismo.Info
- Publication number
- ES2188763T3 ES2188763T3 ES96920364T ES96920364T ES2188763T3 ES 2188763 T3 ES2188763 T3 ES 2188763T3 ES 96920364 T ES96920364 T ES 96920364T ES 96920364 T ES96920364 T ES 96920364T ES 2188763 T3 ES2188763 T3 ES 2188763T3
- Authority
- ES
- Spain
- Prior art keywords
- factor
- relaxine
- methods
- type
- same
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102100033262 Insulin-like 3 Human genes 0.000 abstract 2
- 108091012778 Insulin-like 3 Proteins 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 102000003743 Relaxin Human genes 0.000 abstract 1
- 108090000103 Relaxin Proteins 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/64—Relaxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A UN FACTOR SIMILAR A RELAXINA, A SUS DERIVADOS O ANALOGOS, Y A SUS USOS. LA PRESENTE INVENCION SE REFIERE ADICIONALMENTE A COMPOSICIONES QUE COMPRENDEN UN FACTOR SIMILAR A RELAXINA, SUS DERIVADOS O ANALOGOS, Y A RELAXINA, EN LAS QUE DICHAS COMPOSICIONES MUESTRAN UN EFECTO ADITIVO O SINERGICO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/484,219 US5911997A (en) | 1995-06-07 | 1995-06-07 | Relaxin-like factor and methods and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2188763T3 true ES2188763T3 (es) | 2003-07-01 |
Family
ID=23923245
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96920364T Expired - Lifetime ES2188763T3 (es) | 1995-06-07 | 1996-05-16 | Factor del tipo relaxina y metodos y usos del mismo. |
Country Status (9)
Country | Link |
---|---|
US (2) | US5911997A (es) |
EP (1) | EP0831871B1 (es) |
JP (1) | JP3830520B2 (es) |
AT (1) | ATE229340T1 (es) |
AU (1) | AU709115B2 (es) |
CA (1) | CA2224080C (es) |
DE (1) | DE69625354T2 (es) |
ES (1) | ES2188763T3 (es) |
WO (1) | WO1996040186A1 (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4568383B2 (ja) | 1995-08-15 | 2010-10-27 | コルセラ,インコーポレイティッド | 血管形成の促進方法 |
DE19641378C1 (de) * | 1996-09-27 | 1998-04-02 | Ihf Inst Fuer Hormon Und Fortp | Diagnosehilfe sowie Verfahren zum Nachweis der Trächtigkeit von Wiederkäuern |
GB9717652D0 (en) * | 1997-08-20 | 1997-10-22 | Nycomed Imaging As | Method |
AUPR814401A0 (en) | 2001-10-08 | 2001-11-01 | Howard Florey Institute Of Experimental Physiology And Medicine | Human 3 relaxin |
US20050186526A1 (en) * | 2002-11-01 | 2005-08-25 | Bas Medical, Inc. | Methods and systems for enabling and stabilizing tooth movement |
AU2003903124A0 (en) * | 2003-06-20 | 2003-07-10 | Mark Del Borgo | Analogues of heteromeric proteins |
US7878978B2 (en) * | 2004-03-18 | 2011-02-01 | University Of Pittsburgh- Of The Commonwealth System Of Higher Education | Use of relaxin to increase arterial compliance |
EP1753449A4 (en) * | 2004-04-30 | 2009-09-23 | Corthera Inc | METHOD AND COMPOSITIONS FOR CONTROLLING FEDERAL GROWTH BY RELAXIN MODULATION |
US20060052304A1 (en) * | 2004-09-02 | 2006-03-09 | Bas Medical, Inc. | Method for remodeling bone and related sutures |
WO2007093220A1 (en) * | 2006-02-17 | 2007-08-23 | Associazione Foresta Per La Ricerca Nella Riproduzione Umana | Use of insulin-like factor 3 for treating osteoporosis and bone disorders |
AU2009316278B2 (en) * | 2008-11-24 | 2013-09-26 | Corthera, Inc. | Prediction and prevention of preeclampsia |
PL2605789T3 (pl) | 2010-08-17 | 2019-11-29 | Ambrx Inc | Zmodyfikowane polipeptydy relaksyny i ich zastosowania |
US9567386B2 (en) | 2010-08-17 | 2017-02-14 | Ambrx, Inc. | Therapeutic uses of modified relaxin polypeptides |
AU2012291972B2 (en) * | 2011-08-04 | 2017-03-09 | Pharis Biotec Gmbh | Process for preparing human relaxin-2 |
WO2013177529A1 (en) * | 2012-05-24 | 2013-11-28 | Angion Biomedica Corp. | Relaxin-like compounds and uses thereof |
US9393288B2 (en) | 2012-05-29 | 2016-07-19 | The University Of Vermont And State Agricultural College | Methods of treating diseases associated with PPARγ |
WO2014040008A1 (en) * | 2012-09-10 | 2014-03-13 | Angion Biomedica Corp. | Relaxin-like peptides and uses thereof |
ES2927607T3 (es) | 2013-09-13 | 2022-11-08 | Scripps Research Inst | Agentes terapéuticos modificados y composiciones de los mismos |
EP4212180A1 (en) | 2013-12-18 | 2023-07-19 | The Scripps Research Institute | Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof |
MA41794A (fr) * | 2015-03-18 | 2018-01-23 | The California Institute For Biomedical Res | Agents thérapeutiques modifiés et compositions associées |
WO2017100540A2 (en) | 2015-12-09 | 2017-06-15 | The California Institute For Biomedical Research | Relaxin immunoglobulin fusion proteins and methods of use |
SG10201912034UA (en) | 2017-02-08 | 2020-02-27 | Bristol Myers Squibb Co | Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0101309B1 (en) * | 1982-08-12 | 1991-01-16 | Howard Florey Institute Of Experimental Physiology And Medicine | Molecular cloning and characterization of a gene sequence coding for human relaxin |
US4835251A (en) * | 1986-06-23 | 1989-05-30 | Genetech, Inc. | Method of chain combination |
US5166191A (en) * | 1991-08-19 | 1992-11-24 | Genentech, Inc. | Use of relaxin in cardiovascular therapy |
US5478807A (en) * | 1991-08-19 | 1995-12-26 | Genentech, Inc. | Use of relaxin in the treatment of bradycardia |
-
1995
- 1995-06-07 US US08/484,219 patent/US5911997A/en not_active Expired - Lifetime
-
1996
- 1996-05-16 DE DE69625354T patent/DE69625354T2/de not_active Expired - Lifetime
- 1996-05-16 WO PCT/US1996/007399 patent/WO1996040186A1/en active IP Right Grant
- 1996-05-16 AT AT96920364T patent/ATE229340T1/de active
- 1996-05-16 CA CA2224080A patent/CA2224080C/en not_active Expired - Lifetime
- 1996-05-16 AU AU58699/96A patent/AU709115B2/en not_active Expired
- 1996-05-16 ES ES96920364T patent/ES2188763T3/es not_active Expired - Lifetime
- 1996-05-16 JP JP50064897A patent/JP3830520B2/ja not_active Expired - Lifetime
- 1996-05-16 EP EP96920364A patent/EP0831871B1/en not_active Expired - Lifetime
-
2001
- 2001-04-30 US US09/846,149 patent/US6949506B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH11512072A (ja) | 1999-10-19 |
EP0831871A1 (en) | 1998-04-01 |
DE69625354D1 (de) | 2003-01-23 |
CA2224080C (en) | 2010-07-27 |
JP3830520B2 (ja) | 2006-10-04 |
ATE229340T1 (de) | 2002-12-15 |
US5911997A (en) | 1999-06-15 |
EP0831871A4 (en) | 1999-03-03 |
US6949506B2 (en) | 2005-09-27 |
DE69625354T2 (de) | 2003-10-30 |
CA2224080A1 (en) | 1996-12-19 |
WO1996040186A1 (en) | 1996-12-19 |
US20030158376A1 (en) | 2003-08-21 |
EP0831871B1 (en) | 2002-12-11 |
AU709115B2 (en) | 1999-08-19 |
AU5869996A (en) | 1996-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2188763T3 (es) | Factor del tipo relaxina y metodos y usos del mismo. | |
UA39099C2 (uk) | Циклічні азотовмісні похідні, суміш їх ізомерів або окремі ізомери, або їх солі | |
NO942170L (es) | ||
HU9601449D0 (en) | Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof | |
TR199800825T2 (xx) | Farnesil protein transferini inhibe eden (imidazol-5-il) metil-2-kinolinon t�revleri. | |
JO2034B1 (en) | Isotopes of the hormone peptide its uses and the chemical compounds it contains | |
EE02962B1 (et) | Mometasoonfuroaadi monohüdraat, selle valmistamismeetod ja farmatseutilised kompositsioonid | |
GR82243B (es) | ||
DE69529998D1 (de) | Glp-1 zusammensetzungen mit verlängerter wirkdauer | |
IL107870A0 (en) | Pharmaceutical compositions having antidepressant activity comprising pramipexol | |
DE3168681D1 (en) | D-homo steroids, their utilization and preparation and pharmaceutical compositions containing them | |
IT8122766A0 (it) | Composizioni detergenti, loro preparazione e loro utilizzazione come additivi per carburanti. | |
AR015945A1 (es) | Composiciones de spray para el cabello autofobicas | |
DE3480934D1 (de) | Zusammensetzungen von polyamid-gummi-mischungen. | |
YU4197A (sh) | Smeše koje se mogu izolovati polazeći od semena eugenia jambolana lamarck, njihovo dobijanje i primena ovih smeša i nekih od njihovih sastojaka kao lekova | |
DE69229108D1 (de) | Oxypurin-nukleoside und seine artverwandten, und acylderivate davon, zur verbesserung der hämatopoese | |
EA199800534A1 (ru) | ПРИМЕНЕНИЕ 2-ЭТИЛГЕКСИЛ-α-ЦИАНО-β, β-ДИФЕНИЛАКРИАТА ДЛЯ УЛУЧШЕНИЯ СТАБИЛЬНОСТИ КОСМЕТИЧЕСКИХ КОМПОЗИЦИЙ, СОДЕРЖАЩИХ П-МЕТИЛБЕНЗИЛИДЕНКАМФОРУВ СОЧЕТАНИИ С ДИБЕНЗОИЛМЕТАНОВЫМ ПРОИЗВОДНЫМ | |
DE68920622D1 (de) | Polyketonzusammensetzungen. | |
MX9307203A (es) | COMPUESTOS ESTEROIDALES DE ACIL-3-CARBOXI-3,5-DIENO-17Ó Y 17ß -SUBSTITUIDOS. | |
YU41796A (sh) | Smeše za poboljšanje podnošljivosti delotvornih beta-amino kiselina | |
DK0977871T3 (da) | Neurotrypsin | |
TR200002293T2 (tr) | Farmasötik bileşimler. | |
UA27142C2 (uk) | Фармацевтичhа композиція | |
MX168147B (es) | Composiciones de champu | |
DK0539465T3 (da) | Anvendelse af 20(R)-22-oxa-D-vitamin-analoger til fremstilling af et farmaceutisk præparat til behandling og/eller forebyggelse af hudaldring |